Tecan Reports Mixed 2025 Results, Launches 'Rewired' Transformation Program

Event summary

  • Tecan reported 2025 sales of CHF 882.5 million, down 1.6% in local currencies, with second-half sales growth of 0.4%.
  • Order entry increased by 3.8% in local currencies for the full year and by 8.6% in the second half.
  • Adjusted EBITDA margin decreased to 16.1% from 17.6% due to adverse foreign exchange effects and tariffs.
  • Net loss of CHF 110.7 million due to non-cash impairment charges of CHF 139.5 million.
  • Tecan launched the 'Rewired' transformation program to drive profitable growth and future-proof the company.

The big picture

Tecan's mixed 2025 results reflect broader challenges in the life sciences instrumentation market, including budget uncertainty and volatile public funding. The company's strategic response, the 'Rewired' transformation program, aims to capitalize on long-term trends such as AI integration and automation in laboratory settings. With a strong balance sheet and a focus on portfolio optimization, Tecan is positioning itself to outgrow the market by leading the AI- and data-driven future of laboratory automation.

What we're watching

Transformation Impact
The effectiveness of the 'Rewired' program in driving incremental revenue and operational efficiencies.
Market Recovery
The pace at which end markets recover and whether Tecan can outgrow the market.
Profitability Headwinds
The ability to mitigate foreign exchange and tariff headwinds to achieve the targeted adjusted EBITDA margin.

Related topics

Revenue